Brii Biosciences BRIBF Stock
Brii Biosciences Price Chart
Brii Biosciences BRIBF Financial and Trading Overview
| Brii Biosciences stock price | 0.3 USD |
| Previous Close | 0.42 USD |
| Open | 0.42 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.42 - 0.42 USD |
| 52 Week Range | 0.0028 - 1.25 USD |
| Volume | 736 USD |
| Avg. Volume | 45 USD |
| Market Cap | 368.87M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
BRIBF Valuation Measures
| Enterprise Value | -2716856064 USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.01659 |
| Price/Book (mrq) | 0.09547006 |
| Enterprise Value/Revenue | -22.219 |
| Enterprise Value/EBITDA | 5.37 |
Trading Information
Brii Biosciences Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -66.44% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.25 USD |
| 52 Week Low | 0.0028 USD |
| 50-Day Moving Average | 0.53 USD |
| 200-Day Moving Average | 0.72 USD |
BRIBF Share Statistics
| Avg. Volume (3 month) | 45 USD |
| Avg. Daily Volume (10-Days) | 73 USD |
| Shares Outstanding | 727.6M |
| Float | 530.5M |
| Short Ratio | N/A |
| % Held by Insiders | 5.41% |
| % Held by Institutions | 46.84% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -420.22% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -9.17% |
| Return on Equity (ttm) | -15.14% |
Income Statement
| Revenue (ttm) | 122.28M USD |
| Revenue Per Share (ttm) | 0.17 USD |
| Quarterly Revenue Growth (yoy) | 101.29% |
| Gross Profit (ttm) | N/A |
| EBITDA | -505900992 USD |
| Net Income Avi to Common (ttm) | -484312000 USD |
| Diluted EPS (ttm) | -0.09 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 3B USD |
| Total Cash Per Share (mrq) | 4.12 USD |
| Total Debt (mrq) | 12.66M USD |
| Total Debt/Equity (mrq) | 0.4 USD |
| Current Ratio (mrq) | 13.43 |
| Book Value Per Share (mrq) | 4.393 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -496279008 USD |
| Levered Free Cash Flow (ttm) | -438462016 USD |
Profile of Brii Biosciences
| Country | United States |
| State | N/A |
| City | Beijing |
| Address | Building 7, International Science Park |
| ZIP | 100192 |
| Phone | N/A |
| Website | https://www.briibio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 146 |
Brii Biosciences Limited engages in the research and development of therapies for the treatment of infectious and central nervous system diseases primarily in China and the United States. The company develops BRII-179, BRII-835, and BRII-877, which are in Phase 2 the development of a functional cure for HBV for Hepatitis B; BRII-179, a recombinant protein-based HBV immunotherapeutic candidate that is in Phase 2; and BRII-732 that is in Phase 1 clinical trail and BRII-753, which is in preclinical stage for the treatment of HIV. It also develops BRII-296 for the treatment of PPD/MDD, anxiety, and other depressive disorders; BRII-297 for treatment of various depressive disorders; BRII-636, BRII-672, and BRII-693 for the treatment of multi-drug resistant/extensive drug resistant (MDR/XDR) gram-negative infections; and BRII-658 for oral treatment for patients with chronic NTM lung disease. The company was incorporated in 2017 and is headquartered in Beijing, China.
Q&A For Brii Biosciences Stock
What is a current BRIBF stock price?
Brii Biosciences BRIBF stock price today per share is 0.3 USD.
How to purchase Brii Biosciences stock?
You can buy BRIBF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Brii Biosciences?
The stock symbol or ticker of Brii Biosciences is BRIBF.
Which industry does the Brii Biosciences company belong to?
The Brii Biosciences industry is Biotechnology.
How many shares does Brii Biosciences have in circulation?
The max supply of Brii Biosciences shares is 727.04M.
What is Brii Biosciences Price to Earnings Ratio (PE Ratio)?
Brii Biosciences PE Ratio is now.
What was Brii Biosciences earnings per share over the trailing 12 months (TTM)?
Brii Biosciences EPS is -0.1 USD over the trailing 12 months.
Which sector does the Brii Biosciences company belong to?
The Brii Biosciences sector is Healthcare.